Laporan Laba Rugi (TTM)
Laporan Laba Rugi Nath Bio-Genes (India) Limited menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.
Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3,097 | 3,127 | 3,076 | 3,289 | 3,205 | 3,062 | 2,784 | 2,731 | 2,799 | 2,836 | 3,014 | 3,273 | 3,281 | 3,346 | 3,328 | 3,414 | 3,510 | 3,561 | 3,650 | 4,047 |
| Change (%) | 0.96 | -1.64 | 6.95 | -2.56 | -4.48 | -9.08 | -1.90 | 2.52 | 1.30 | 6.27 | 8.60 | 0.26 | 1.96 | -0.54 | 2.58 | 2.82 | 1.46 | 2.50 | 10.87 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 1,103 | 1,111 | 980 | 1,151 | 1,115 | 1,023 | 937 | 823 | 878 | 952 | 814 | 1,008 | 1,001 | 1,046 | 903 | 841 | 923 | 907 | 902 | 1,525 |
| Change (%) | 0.71 | -11.79 | 17.41 | -3.10 | -8.24 | -8.46 | -12.15 | 6.73 | 8.40 | -14.46 | 23.78 | -0.72 | 4.55 | -13.68 | -6.91 | 9.82 | -1.79 | -0.46 | 68.93 | |
| % of Revenue | 35.62 | 35.53 | 31.87 | 34.98 | 34.79 | 33.42 | 33.65 | 30.13 | 31.37 | 33.57 | 27.02 | 30.80 | 30.50 | 31.27 | 27.14 | 24.63 | 26.30 | 25.46 | 24.72 | 37.67 |
| Gross Operating Profit | 1,994 | 2,016 | 2,095 | 2,139 | 2,090 | 2,038 | 1,847 | 1,908 | 1,921 | 1,884 | 2,199 | 2,265 | 2,281 | 2,300 | 2,425 | 2,573 | 2,587 | 2,655 | 2,748 | 2,523 |
| Change (%) | 1.10 | 3.95 | 2.06 | -2.27 | -2.48 | -9.39 | 3.30 | 0.70 | -1.95 | 16.74 | 2.99 | 0.69 | 0.83 | 5.44 | 6.12 | 0.53 | 2.62 | 3.52 | -8.19 | |
| % of Revenue | 64.38 | 64.47 | 68.13 | 65.02 | 65.21 | 66.58 | 66.35 | 69.87 | 68.63 | 66.43 | 72.98 | 69.20 | 69.50 | 68.73 | 72.86 | 75.37 | 73.70 | 74.54 | 75.28 | 62.33 |
| SG&A | 424 | 439 | 411 | 412 | 373 | 325 | 382 | 511 | 589 | 567 | 372 | 421 | 425 | 440 | 442 | 509 | 535 | 586 | 522 | 1,690 |
| Change (%) | 3.55 | -6.42 | 0.13 | -9.39 | -12.89 | 17.64 | 33.77 | 15.29 | -3.86 | -34.26 | 13.10 | 0.91 | 3.49 | 0.50 | 15.20 | 5.10 | 9.50 | -10.90 | 223.61 | |
| % of Revenue | 13.69 | 14.04 | 13.36 | 12.51 | 11.63 | 10.61 | 13.73 | 18.72 | 21.05 | 19.98 | 12.36 | 12.87 | 12.96 | 13.15 | 13.29 | 14.92 | 15.25 | 16.46 | 14.31 | 41.76 |
| R&D | ||||||||||||||||||||
| Change (%) | ||||||||||||||||||||
| % of Revenue | ||||||||||||||||||||
| OpEx | 2,500 | 2,526 | 2,432 | 2,604 | 2,529 | 2,389 | 2,438 | 2,521 | 2,586 | 2,626 | 2,555 | 2,793 | 2,796 | 2,865 | 2,860 | 2,950 | 3,048 | 3,076 | 3,179 | 3,572 |
| Change (%) | 1.03 | -3.72 | 7.04 | -2.85 | -5.53 | 2.03 | 3.42 | 2.57 | 1.56 | -2.72 | 9.31 | 0.10 | 2.48 | -0.16 | 3.13 | 3.34 | 0.92 | 3.34 | 12.35 | |
| % of Revenue | 80.73 | 80.79 | 79.08 | 79.15 | 78.91 | 78.04 | 87.58 | 92.33 | 92.38 | 92.61 | 84.78 | 85.33 | 85.19 | 85.62 | 85.95 | 86.40 | 86.84 | 86.38 | 87.08 | 88.24 |
| Operating Income | 597 | 601 | 643 | 686 | 676 | 672 | 346 | 209 | 213 | 209 | 459 | 480 | 486 | 481 | 468 | 464 | 462 | 485 | 471 | 476 |
| Change (%) | 0.66 | 7.08 | 6.62 | -1.44 | -0.56 | -48.58 | -39.40 | 1.84 | -1.82 | 119.02 | 4.66 | 1.18 | -0.99 | -2.78 | -0.75 | -0.50 | 5.04 | -2.79 | 0.92 | |
| % of Revenue | 19.27 | 19.21 | 20.92 | 20.85 | 21.09 | 21.96 | 12.42 | 7.67 | 7.62 | 7.39 | 15.22 | 14.67 | 14.81 | 14.38 | 14.05 | 13.60 | 13.16 | 13.62 | 12.92 | 11.76 |
| Interest Expense | -71 | -76 | -79 | -86 | -94 | -100 | -101 | -104 | -103 | -106 | -96 | -93 | -90 | -89 | -86 | -81 | -86 | -97 | -99 | -114 |
| Change (%) | 6.55 | 4.33 | 8.63 | 8.93 | 6.47 | 1.70 | 2.23 | -0.29 | 2.43 | -9.44 | -2.75 | -3.37 | -1.31 | -2.81 | -6.07 | 6.68 | 12.28 | 1.97 | 15.55 | |
| % of Revenue | -2.30 | -2.42 | -2.57 | -2.61 | -2.92 | -3.25 | -3.64 | -3.79 | -3.69 | -3.73 | -3.18 | -2.84 | -2.74 | -2.65 | -2.59 | -2.37 | -2.46 | -2.73 | -2.71 | -2.83 |
| Net Income | 558 | 562 | 557 | 593 | 575 | 561 | -674 | -815 | -813 | -827 | 350 | 374 | 379 | 399 | 396 | 398 | 394 | 382 | 386 | 425 |
| Change (%) | 0.62 | -0.87 | 6.56 | -3.01 | -2.50 | -220.13 | 21.01 | -0.35 | 1.80 | -142.33 | 6.92 | 1.22 | 5.40 | -0.80 | 0.38 | -1.00 | -2.88 | 0.95 | 10.17 | |
| % of Revenue | 18.02 | 17.96 | 18.10 | 18.03 | 17.95 | 18.32 | -24.21 | -29.86 | -29.02 | -29.17 | 11.62 | 11.44 | 11.55 | 11.94 | 11.91 | 11.65 | 11.22 | 10.74 | 10.57 | 10.51 |
Source: Capital IQ
